Search

Your search keyword '"Zeller, Daniel"' showing total 333 results

Search Constraints

Start Over You searched for: Author "Zeller, Daniel" Remove constraint Author: "Zeller, Daniel"
333 results on '"Zeller, Daniel"'

Search Results

1. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2

2. Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study

3. Head movement dynamics in dystonia: a multi-centre retrospective study using visual perceptive deep learning

5. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany

9. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study

12. Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022

14. SARS-CoV-2 Antigen Rapid Detection Tests: test performance during the COVID-19 pandemic and the impact of COVID-19 vaccination

18. Lesions causing Alice in Wonderland Syndrome map to a common brain network linking body and size perception

19. The sensitivity of rapid tests for SARS-CoV-2 antigen

21. In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.

23. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

26. Prognostic factors in ALS: a comparison between Germany and China

28. Clinical and genetic features of amyotrophic lateral sclerosis patients with C9orf72 mutations

29. Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis

30. Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosis

32. Improvements in Walking Distance during Nusinersen Treatment : A Prospective 3-year SMArtCARE Registry Study

33. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

35. Hot-spot KIF5A mutations cause familial ALS

37. AA amyloidosis in inflammatory active malignant paraganglioma

38. Smartphone video nystagmography using convolutional neural networks: ConVNG

39. Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy

40. Virus Variant Specific Clinical Performance Assessment of SARS-CoV-2 Rapid Antigen Tests in Point-of-Care Use Including Omicron VOC

46. Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives

47. Life Course of Physical Activity and Risk and Prognosis of Amyotrophic Lateral Sclerosis in a German ALS Registry

48. Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives

Catalog

Books, media, physical & digital resources